baber/WOPTO huggingface dataset:
Patent FI-890796-A0 (FI)
Inventor: JEFFREY ROBERT FRASER
IPC: F41H3/00
Filed: 1989-02-17
Abstract: A thermal camouflage fabric (12) comprising a heat reflective composite material (14, 16) which is coated on both of its sides with a protective material (18), the heat reflective composite material (14, 16) comprising at least one layer of a metal (14) and at least one layer of a flexible support material (16), the protective material (18) being such that it protects the heat reflective composite material (14, 16) from damage and such that it has predetermined thermal emission characteristics, the protective material (18) being securely bonded to the heat reflective composite material (14, 16), and the thermal camouflage fabric (12) being such that the heat reflective composite material (14, 16) is first formed from the said at least one layer of the metal (14) and the said at least one layer of the flexible support material (16), and is then woven.
Patent FI-901857-A0 (FI)
Inventor: SENDELWECK GENE KARL
IPC: H04N9/64
Filed: 1990-04-12
Abstract: An auxiliary video input terminal (S-terminal) couples luminance amd chrominance input signals to respective inputs of peaking circuits (52, 58) in the display processor (40) of a receiver. The chrominance input signal is subjected to pre-distortion (de-peaking) (80) to correct for sideband amplitude distortion in the chrominance peaking filter of the receiver thereby preventing color distortion in displayed images. The luminance signal is subjected to additional peaking (52) at a frequency greater than the characteristic peaking frequency of the luminance peaking filter thereby enhancing the sharpness of wideband luminance input signals displayed by the receiver. <IMAGE>
Patent FI-902470-A0 (FI)
Inventor: ALBINSSON URBAN
IPC: B01F15/00
Filed: 1990-05-18
Abstract: A drive device for an impeller (17) which is rotatably mounted within a vessel (11) for stirring and mixing sterile fluids. The drive device is rotatably mounted at an inwardly-directed cylindrical recess (15) in a bottom wall (16) of the vessel, the recess (15) being intended to receive the drive device. The impeller (17) includes a peripheral section (21) which surrounds the cylindrical recess (15). A stator (24) is fixedly secured in the recess (15), which stator includes a magnetisable iron core (25) and induction coils connectable to a 3-phase alternating current source. Inductively magnetisable elements 23 are located in the peripheral section (21) of the impeller (17) for generating a torque when the stator (24) is supplied with a 3-phase alternating current so that the impeller rotates in a predetermined direction.
Patent FI-910768-A0 (FI)
Inventor: BREANT PATRICE
IPC: C08K5/17
Filed: 1991-02-18
Abstract: The sliding, anti-blocking and optical quality compositions are comprised of at least one ethylene copolymer having a cristallinity not exceeding 30 %; they are characterized in that they further include an efficient quantity of ethylene-bis-oleamide. Said compositions may be conveniently used for the fabrication of plates with a thickness comprised between 1 and 10 mm approximately, and particularly for the production of films with a thickness comprised between 10 and 500  mu m approximately.
Patent FI-912491-A0 (FI)
Inventor: CAMPION COLIN
IPC: C07C317/44
Filed: 1991-05-22
Abstract: Compounds of general formula I:    <IMAGE>  (I)  wherein: R1 represents a C1-C6 alkyl, phenyl, thiophenyl, substituted phenyl, phenyl(C1-C6)alkyl, heterocyclyl, (C1-C6)alkylcarbonyl phenacyl or substituted phenacyl group; or, when n=O, R1 represents SRx, wherein Rx represents a group:   <IMAGE>   R2 represents a hydrogen atom or a C1-C6 alkyl, C1-C6 alkenyl, phenyl(C1-C6)alkyl, cycloalkyl(C1-C6)alkyl or cycloalkenyl(C1-C6)alkyl group; R3 represents an amino acid residue with R or S stereochemistry or a C1-C6 alkyl, benzyl, (C1-C6 alkoxy)benzyl or benzyloxy(C1-C6 alkyl) group; R4 represents a hydrogen atom or a C1-C6 alkyl group; R5 represents a hydrogen atom or a methyl group; n is an integer having the value 0, 1 or 2; and A represents a C1-C6 hydrocarbon chain, optionaly substituted with one or more C1-C6 alkyl, phenyl or substituted phenyl groups; and their salts and N-oxides are collagenase inhibitors are and useful in the management of disease involving tissue degradation and/or the promotion of wound healing. Diseases involving tissue degradation include arthropathy (particularly rheumatoid arthritis), inflammation, dermatological diseases, bone resorption diseases and tumor invasion.
Patent FI-925004-A0 (FI)
Inventor: HAGIWARA HIDEAKI
IPC: C12R1/89
Filed: 1992-11-05
Abstract: A vector plasmid containing the Ori A region of plasmid pBA1 derived from Anacystis nidulans, the multicloning region and the Ori E region of colicin E1 plasmid and being freed from the gene defined by the rop region. It can be replicated in the cells of Escherichia coli and cyanobacteria and is useful as a shuttle vector. <IMAGE>
Patent FI-932839-A0 (FI)
Inventor: RAJAIAH JAYANTH
IPC: A61K6/00
Filed: 1993-06-18
Abstract: Stabilizer compositions including specific mixed partial salts of a lower alkyl vinyl ether-maleic acid copolymer, the partial salts containing from about 15% to about 40% free acid, are disclosed. The cationic salt function is from about 0.1% to about 9.9% zinc or strontium cations, and from about 20% to about 67% calcium cations of the total initial carboxyl groups are reacted. Also disclosed are denture stabilizing compositions including a safe and adhesively effective amount of two or more denture adhesive components where one of the denture adhesive components is the above mixed partial salt.
Patent FI-934204-A0 (FI)
Inventor: SWEETEN THEODORE P
IPC: F01M9/02
Filed: 1993-09-24
Abstract: Apparatus for receiving crankcase emissions from an internal combustion engine and for separating the liquid portions of the emissions from the gaseous portion thereof. The apparatus includes a mounting flange, an opening for the return of the liquids to the engine, and at least one layer of filtering material. In one embodiment, the filtering material may be soaked with oil. Another embodiment has a screw mounted in the housing, and positioned to retard the flow of emissions exiting from the housing. The apparatus includes an outlet for return of the gaseous portion of the emissions to return to the combustion chamber via the PCV line or the induction manifold.
Patent FI-951319-A0 (FI)
Inventor: NEUNER KARL
IPC: A43B13/38
Filed: 1995-03-21
Abstract: The shoe upper extends with its lower edge parallel to the outer surface of the lip of the inner sole, and is connected to it. The inner sole and lip consist of one piece. The inner sole has a recess in the area of the ball of the foot. A steel shank, heel support etc,. may be positioned in this area of the shoe/boot. <IMAGE>
Patent AP-9701053-A0 (AP)
Title: Safety detaching hooks.
Inventor: SIMS ALAN
Filed: 1997-08-06
Abstract: A safety detaching hook 10 includes a pair of scissor plates 12, 14 which are mounted on a pivot pin 32 for pivotal displacement relative to one another between a normally closed condition and an open condition. The scissor plates 12, 14 are positioned between outer plates 28, 30. The scissor plates 12, 14 each have a curved catch plate striking formation 16 which striking formations, in the closed condition of the scissor plates curve downwardly outwardly and protrude in opposite directions from between the outer plates 28, 30.
Patent IL-75372-A0 (IL)
Title: Pharmaceutical compositions of sparingly soluble medicaments for oral administration
IPC: A61K9/52
Filed: 1985-05-31
Abstract: A pharmaceutical composition comprising a plurality of, beads constituting a unit dose of a solid steroid medicament enclosed in a gastric-juice soluble material, for example gelatin capsules. Each bead comprises finely divided discrete solid steroidal particles bound onto a particulate core by a binder soluble in water.
Patent IL-88514-A0 (IL)
Title: Substituted propane-phosphinic acid compounds
IPC: A61P25/26
Filed: 1988-11-28
Abstract: Compounds of the formula I <CHEM> wherein R denotes an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic or araliphatic radical having 2 or more carbon atoms, and wherein one of the groups R<1>, R<2> and R<3> represents hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another one of R<1>, R<2> and R<3> is hydrogen or, in the case of R<1> and R<2>, is hydroxy, and the remaining one of R<1>, R<2> and R<3> is hydrogen, and their salts have GABAB-antagonistic properties and can be used as GABAB-antagonists. They are obtained when in a compound of formula II <CHEM> in which R, R<1>, R<2> and R<3> have their previous significances, Z represents -NH2 and R<4> denotes a hydroxy-protective group R<5> or, when R<1> and R<3> denote hydrogen and R<2> denotes hydrogen or alkyl, denotes an alkali metal or ammonium ion R<6>, or Z represents a protected or latent amino group Z<0> and R<4> denotes hydrogen or a hydroxy-protective group R<5>, any group R<5> or R<6> is replaced by hydrogen, and/or any group Z<0> is converted into -NH2.
Patent IL-92829-A0 (IL)
Title: Xanthine derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61P9/00
Filed: 1989-12-21
Abstract: Xanthines of formula (I) and their optical isomers and acid-addn. salts are new: R1 = 1-6C alkyl, 3-4C alkenyl or 3-4C alkynyl; R2 = 1-6C alkyl, 3-4C alkenyl, 3-4C alkynyl or opt. substd. benzyl; R3 = (a) C-bonded satd. or unsatd. 5- to 7-membered heterocyclyl contg. one or more O and/or S atoms, opt. substd. by 1-6C alkyl, oxo, CHO, CH2OR4, CH2OR7, COOR4 or CONR5R6; where furyl and thienyl gps. are opt. also substd. and tetrahydrofuryl gps. are opt. also substd; (b) 4-8C cycloalkenyl opt. substd. by 2-4C alkenyl; (c) a 4-8C cycloalkanone or cycloalkanol gp. opt. alpha-substd. by 2-6C alkenyl, 2-6C alkynyl, opt. substd. benzyl, CH2OR4, CH2COOR7 or CH2CH2CN; (d) 3-8C cycloalkyl opt. substd. by 1-6C alkyl, =CH2, =NNHAr, =NNHR, =NOH, OCONHAr, OCONHR, OR4, OR7, (CH2)xCOOR4, (CH2)xNR4R4, (CH2)xCONR5R6, (CH2)xOR4, (CH2)xOR7 or =CHA; (e) 3-8C cycloalkyl gem-substd. by OH and 1-6C alkyl, vinyl, allyl or opt. substd. phenyl or (1-4C alkyl)phenyl; (f) 3-8C cycloalkyl gem-substd. by ORa and ORb, or (g) 3,4-methylenedioxyphenyl, 3,4-ethylenedioxyphenyl, 2-fluorenyl, 9-fluorenyl or a bicyclic gp., e.g. of formula (i)-(iii). Ar = opt. substd. aryl; R = 1-6C alkyl, x = 0-4; A = COOR4, CN, CONR5,R6, CH=CHCOOR4, CH=CHCONR5R6, CH2OR4 or CH2OR7; Ra and Rb = 1-4C alkyl, or Ra+Rb = 2-3C alkylene opt. substd. by 1 or 2 of 1-5C alkyl, 2-6C alkoxycarbonyl and 1-5C hydroxyalkyl; R4 = H, 1-13C alkyl, 3-13C alkenyl, propargyl, trityl or opt. substd. 3-6C cycloalkyl or benzyl; R5 = H, 1-6C alkyl or opt. substd. 3-6C cycloalkyl; R6 = H, 1-6C alkyl, opt. substd. benzyl, (CH2)nNR5R5, ((CH2)nO(CH2)mO)k(CH2)nNR5R5, (CH2)nQ(CH2)nNR5R5, or C-bonded piperidinyl opt. substd. ; or NR5R6 is a 5- to 7-membered ring opt. contg. another heteroatom and opt. substd. ; n = 2-8; m = 2-6; k = 0 or 1; Q = piperazine-1,4-diyl opt. substd. ; R7 = acyl derived from a natural amino acid, 2-14C alkanoyl, methyloxyacetyl, camphanoyl, abietoyl, 4-aminobutyryl, opt. substd. benzoyl or COB1; B1 = opt. substd.
Patent IL-96006-A0 (IL)
Title: Polymers with imide groups
IPC: C08L79/08
Filed: 1990-10-15
Abstract: Novel thermostable imido copolymers, well adapted for the production of prepregs useful in the fabrication of multilayer circuits, are prepared by copolymerizing (a) at least one N,N'-bis-maleimide with (b) at least one sterically hindered diprimary diamine, (c) optionally, at least one ethylenically unsaturated non-halogenated comonomer other than a bis-imide (a), (d) optionally, a free radical polymerization initiator, (e) at least one comonomer including a chlorinated or brominated epoxy resin, an N,N'-alkylene-bis-tetrahalogenophthalimide, a compound containing two phenyl radicals directly joined va a single valence bond, a divalent radical or a bridging atom, wherein such compound each phenyl radical is substituted by a (meth)allyloxy radical and by at least two chlorine or bromine atoms, and/or a non-halogenated epoxy resin, and (f) at least one alkenylphenol.
Patent IL-98502-A0 (IL)
Title: Aminoalkane phosphinic acid derivatives,process for their preparation and pharmaceutical compositions containing them
IPC: A61K31/685
Filed: 1991-06-14
Abstract: Compounds having GABAB-antagonistic properties, for example those of formula I    <IMAGE>  (I)  wherein one of the radicals R1, R2 and R3 is hydrogen or an aliphatic, cycloaliphatic, araliphatic or aromatic radical, another is hydrogen or, in the case of R1 or R2, hydroxy or, in the case of R1, halogen or, in the case of R2 together with R2', oxo, and the remaining radical is hydrogen, R1' is hydrogen or halogen, R2' is hydrogen, hydroxy or, together with R2, is oxo, R4 and R5 are hydrogen or R4 is an araliphatic or heteroarylaliphatic radical and R5 is hydrogen or an aliphatic radical, and R is an aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, araliphatic, heteroarylaliphatic or aromatic radical having at least 2 carbon atoms or, when R1 is hydrogen or hydroxy, R2 is an aromatic radical and R1', R2' and R3 are hydrogen, R is methyl, and their pharmaceutically acceptable salts, can be used as active ingredients in medicaments for the treatment of epilepsies of the "petit mal"  type. The invention relates also to novel compounds of formula I and processes for the preparation thereof.
Patent AU-PN952696-A0 (AU)
Title: New heterocyclic compounds
IPC: C07D521/00
Filed: 1996-04-29
Abstract: PCT No. PCT/JP97/01415 Sec. 371 Date Oct. 26, 1998 Sec. 102(e) Date Oct. 26, 1998 PCT Filed Apr. 24, 1997 PCT Pub. No. WO97/15877 PCT Pub. Date Apr. 24, 1997A compound of the formula: wherein R1 is lower alkyl, R2 is hydrogen, lower alkyl or a heterocyclic group, R3 is hydrogen, lower alkyl or halogen, R4 is lower alkyl or halogen, R5 is nitro or amino substituted with substituent(s) selected from the group consisting of lower alkyl and acyl, and A is lower alkylene.
Patent FI-20085703-A0 (FI)
Inventor: VAIRINEN ERKKI
IPC: F24F/
Filed: 2008-07-07
Abstract: The invention relates to an air grate (1) comprising a plurality of elongated bars (3) spaced from one another in such a way that an air passage (4) is formed between adjacent bars. The bars are interconnected by means of transverse joining pieces at least at two points spaced from one another by a longitudinal spacing between the bars. The bars are formed as separate profiled parts (3), on one longitudinal edge of which is formed a connecting piece (5), the thickness of which decreases inwards from the outer edge. The that the transverse joining piece is comprised of a connecting profile (6), on which receiving grooves (10) are formed for receiving the connecting pieces (5) by pushing the profiled parts (3) by their longitudinal movement with respect to the said connecting profile, and of a fixing lath (7) positioned on the connecting profile and having an essentially U- or C-shaped cross- section. The limbs of the fixing lath are dimensioned in such a way that when the fixing lath (7) is fastened to the connecting profile (6), the limbs of the U settle tightly against the outer edge (5a) of the profiled parts (3), thus locking the profiled parts (3) into place with respect to the connecting profile (6).
Patent FI-20110104-A0 (FI)
Inventor: DE GODZINSKY CHRISTIAN
IPC: A61B/
Filed: 2011-03-21
Abstract: The invention relates to an intra-oral x-ray imaging arrangement which includes an imaging sensor (30) arranged positionable within a patient's mouth and a control system of the imaging arrangement. The control system is arranged in functional connection with a means that has been arranged to send measurement signals to the control system informing on position of at least one component included in the arrangement. In connection with the imaging sensor (30), and a radiation source (4) included in the arrangement, means (A, M, G) have been arranged to measure their spatial position and to send measurement signals based on these measurements to the control system arranged with a means to determine, based on said measurement signals, information on mutual spatial position of the imaging sensor (30) and the radiation source (4), or of a component (40, 50) arranged to the radiation source (4).
Patent FI-20115337-A0 (FI)
Inventor: LIIMATAINEN TOMMI
IPC: C21D/
Filed: 2011-04-08
Abstract: The invention relates to a method for producing a steel product, such as a steel plate, having a thickness of 2-60 mm, from a steel billet, which is produced from steel comprising iron and residue contents as well as unavoidable impurities. The steel comprises, as percentages by weight, C: 0,3-0,6%, Al: 1,0-2,5%, and V: 0-0,4%. The method comprises a step, in which to the steel billet is performed annealing for austenitizing at a temperature of 1000-1300°C, more preferably 1050-1220°C. The invention also relates to a steel product, such as a steel plate, having a thickness of 2- 60 mm.
Patent IL-112796-A0 (IL)
Title: Fibrous culture substrate based on cellulose ester
IPC: A01G1/00
Filed: 1995-02-27
Abstract: Substrate for the culture of plant reproduction material, said substrate essentially consisting of a lower aliphatic ester acid and cellulose-based non sterile fibrous material. The substrate of the invention can contain an agrochemical active material.
Patent IL-114354-A0 (IL)
Title: Compositions comprised of nanoparticles containing butylene oxide-ethylene oxide copolymer surfactants
IPC: A61K47/34
Filed: 1995-06-27
Abstract: This invention provides a composition comprised of nanoparticles containing a therapeutic or diagnostic agent having a nonionic polymeric surfactant as a surface modifier adsorbed on the surface thereof, the surfactant being a block copolymer of ethylene oxide and butylene oxide and a method of making such nanoparticles. The compositions exhibit reduced macrophage uptake and improved toxicological profiles and facilitate particle size reduction such that milling time can be reduced and/or sterile filtration of the nanoparticles can be accomplished.
Patent IL-118333-A0 (IL)
Title: Cyclic peptide antifungal agents
IPC: A61P31/04
Filed: 1996-05-20
Abstract: Provided are pharmaceutical formulations, and methods of inhibiting fungal and parasitic activity using a compound of formula I <CHEM>  wherein : R', R'', R"', R<x1>, R<x2>, R<y1>, R<y2>, R<y3>, R<y4> and R<0> are as defined hereinabove; and     R<2> is <CHEM>     R<3> is <CHEM>   <CHEM>   <CHEM>  or <CHEM> R<3a>, R<3b>, R<3c> and R<3d> are independently hydrogen, C1-C12 alkyl, C2-C12 alkynyl, C1-C12 alkoxy, C1-C12 alkylthio, halo, or -O-(CH2)m-ÄO-(CH2)nÜp-O-(C1-C12 alkyl) or -O-(CH2)q-X-R<4>;     m is 2, 3 or 4;     n is 2, 3 or 4;     p is 0 or 1;     q is 2, 3 or 4;     X is pyrrolidino, piperidino or piperazino; and R<4> is hydrogen, C1-C12 alkyl, C3-C12 cycloalkyl, benzyl or C3-C12 cycloalkylmethyl; or a pharmaceutically acceptable salt thereof.b
Patent IL-129368-A0 (IL)
Title: Immunogenic TLP composition
IPC: A61K38/03
Filed: 1997-10-09
Abstract: The present invention relates to an immunogenic composition comprising at least one protein from TLP or a fragment thereof, and in particular to the compositions wherein said fragments can comprise at least one of the peptides claimed as SEQ ID NO. 1, SEQ ID NO. 2 and SEQ ID NO. 3 in the European Patent No. 9391641.0, or the peptide claimed as SEQ ID NO. I In the Italian Patent Application No. RM96A000496, suitable in therapy against tumoral diseases, and in particular against NSCLC and uro-genital cancer.
Patent IL-138791-A0 (IL)
Title: Improved immunodiagnostic assays using reducing agents
IPC: A61K38/00
Filed: 1999-04-15
Abstract: The present invention relates to a method for purifying a cysteine containing recombinantly expressed protein comprising at least 2, preferably 3 or 4 and even more preferably all of the following steps:  (a) sulphonation of a lysate from recombinant host cells or lysis of recombinant host cells in the presence of guanidinium chloride followed by a subsequent sulphonation of the cell lysate, (b) treatment with a zwitterionic detergent, preferably after removal of the cell debris, (c) purification of the sulphonated version of the recombinant protein or purification of the sulphonated version of the recombinant protein with subsequent removal of the zwitterionic detergent, with said purification being preferably chromatography, more preferably a Ni-IMAC chromatography with said recombinant protein being a His-tagged recombinant protein, (d) desulphonation of the sulphonated version of the recombinant protein, preferably with a molar excess of DTT, (e) storage in the presence of a molar excess of DTT.
Patent IL-141150-A0 (IL)
Title: Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both
IPC: C07D253/07
Filed: 1999-08-18
Abstract: Nitrogen-containing heterocyclic carboxamide derivatives represented by the following general formula: <CHEM> wherein ring A is a substituted or unsubstituted pyrazine, pyrimidine, pyridazine or triazine ring; R<1> is O or OH; R<2> is a hydrogen atom, an acyl group or a substituted or unsubstituted carbamoylalkyl or carboxyalkyl group; and the broken line represents a single bond or a double bond; or salts thereof are useful for preventing and treating virus infections and especially influenza virus infections.
Patent IL-146378-A0 (IL)
Title: Alpha v integrin receptor antagonists
IPC: C07D221/00
Filed: 2000-05-30
Abstract: The present invention relates to novel nonanoic acid derivatives, their synthesis, and their use as alphav integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors alphavbeta3 and alphavbeta5 and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, inflammatory arthritis, viral disease, cancer, and metastatic tumor growth.
Patent IL-150668-A0 (IL)
Title: A method and apparatus for reducing ram size while maintaining fast data access
IPC: G06F17/30
Filed: 2001-01-19
Abstract: A method and apparatus for reducing the amount of RAM required while maintaining fast data access. Data records are often saved in nonvolatile memory in order to maintain the contents of the data records even when the circuit is powered down. In the present invention each record in the nonvolatile RAM collection of data records is input to a function H(x) that outputs a tag value. The calculated tag value is saved in predetermined memory locations in RAM. Each calculated tag is shorter in length than the record saved in nonvolatile RAM. Therefore less RAM is required to save one tag value for each data record than is required to save the entire collection of data records in RAM. The value of H(y) is calculated when a data record entry corresponding to y is desired. Then the value of H(y) is compared to all the values in the tag value table. If a match is found, the corresponding record from its location in non-volatile RAM is retrieved and compared to y. If the values do not match the tag value table is searched for another location matching H(y). The result is a very fast comparison with the contents of nonvolatile RAM requiring only a minimal amount of RAM.